Welcome to our dedicated page for NOVA LTD. SEC filings (Ticker: NVMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nova Ltd. filings document its foreign private issuer reporting for a semiconductor metrology and process control company. Form 6-K current reports incorporate press releases on financial results, scheduled earnings releases, investor conference participation, product adoption for Nova Metrion®, and other operating updates. The Form 20-F annual report includes audited consolidated financial statements and establishes the company's reporting framework under Form 20-F rather than Form 40-F.
The filing record also identifies Nova's Nasdaq ticker NVMI and TASE trading status. Current reports preserve formal notices for annual-report availability, scheduled conference calls and public communications made under Exchange Act Rule 13a-16 or 15d-16.
Company submitted a Form 144 notice listing proposed sales of ordinary shares arising from Restricted Stock Units. The excerpt lists three RSU grant dates and quantities: 1,704 RSUs (05/18/2023), 730 RSUs (06/20/2024) and 1,814 RSUs (06/23/2022). The filing names Oppenheimer & Co. Inc. as a broker with an address at 85 Broad St., New York.
Nova Ltd. filed a Form 6-K to share a press release announcing that its management team will take part in several upcoming investor conferences and events in May and June 2026. These appearances include virtual one-on-one meetings, an in-person investor bus tour, and multiple fireside chats in California.
Chief Executive Officer Gaby Waisman and Chief Financial Officer Guy Kizner will host sessions in Fremont and San Francisco, with live webcasts of the Evercore and Bank of America fireside chats accessible through Nova’s investor relations website. The release also reiterates Nova’s role as a provider of metrology and process control solutions for semiconductor manufacturing and includes standard forward-looking statement language outlining business and macro risks.
NVMI submitted a Form 144 reporting proposed sales of Ordinary shares through Oppenheimer & Co. Inc.. The filing lists 1,246 shares with an aggregate value of $634,400.90, and a reported outstanding share figure of 31,780,111 as of 05/18/2026. The filing also itemizes previously issued Restricted Stock Units granted on 06/23/2022 (1,814 RSUs), 05/18/2023 (1,704 RSUs) and 06/20/2024 (730 RSUs).
NVMI filing reports a resale under Rule 144 by an affiliate. The filing records a sale of 55 ordinary shares on 04/02/2026 with aggregate consideration of $23,375.00. The filing also lists 1,704 Restricted Stock Units dated 05/18/2023 associated with the issuer.
Nova Ltd. has called its annual shareholder meeting for June 18, 2026 in Rehovot, Israel. Holders of ordinary shares at the close of business on May 19, 2026 may vote, with 31,806,161 shares outstanding as of May 12, 2026.
Shareholders are asked to re-elect six current directors and elect Rami Hadar, keeping a seven-member board where six directors are Nasdaq‑independent. A second proposal seeks approval of amended employment terms for President and CEO Gabriel Waisman and aligned changes to the executive compensation policy, including a higher base salary and new performance share units tied to relative total shareholder return plus updated bonus weightings, while maintaining an overall cap of 10% of non‑GAAP operating profit for annual executive bonuses.
The third proposal would re‑appoint Kost Forer Gabbay & Kasierer, a member of EY Global, as independent auditors until the next annual meeting. Proposal 2 is subject to a special voting test that excludes controlling and other Interested Shareholders from the approving majority tally, and the vote on CEO pay is binding under Israeli law, with only limited circumstances permitting a board override.
Nova Ltd. reported record first-quarter 2026 results, with revenue of $235.3 million, up 6% from the previous quarter and 10% year over year. GAAP net income was $69.3 million, or $2.04 per diluted share, and non-GAAP net income was $80.3 million, or $2.33 per diluted share. Gross margin reached 57.7%, slightly higher than both comparison periods, while operating expenses declined sequentially. Management highlighted all-time highs across service revenue and multiple product lines and issued second-quarter 2026 non-GAAP EPS guidance of $2.34–$2.48 per diluted share.
NOVA LTD ownership amendment filed by FMR LLC reports beneficial ownership of 2,759,193 shares of common stock, representing 8.7% of the class as of 03/31/2026. The filing states that Select Semiconductors Portfolio holds 1,928,080 shares (6.1%) as of 03/31/2026. The amendment is executed under a power of attorney and cites an attached Exhibit 99 and a prior Exhibit 24 reference.
Nova Ltd. announced that it will release its first quarter 2026 financial results before the Nasdaq market opens on Thursday, May 14, 2026. Management will host a conference call the same day at 8:30 a.m. Eastern Time, with access via U.S., Israel and international dial-in numbers and a live webcast.
The call replay will be available from May 14 to May 21, 2026. Nova also reiterates that its business involves various risks, including technology, geopolitical, market, supply-chain and regulatory factors, as outlined in its Form 20-F risk factors.
NOVA LTD. director Yaniv Garty reported an open-market sale of 55 Ordinary Shares on April 2, 2026 at $425.00 per share. After this transaction, he directly holds 2,464 shares, including 184 ordinary shares and multiple restricted share unit (RSU) awards.
The RSU holdings include 55 RSUs, 852 RSUs, and 546 RSUs scheduled to vest in equal annual installments through 2027 and 2028, and an additional 827 RSUs that are scheduled to vest in full on June 18, 2026, all contingent on continued service.
Nova Ltd. director Zehava Simon has filed an initial ownership report for Ordinary Shares of the company. The Form 3 lists several direct holdings, with visible position sizes such as 184, 454, 546, 827 and 852 Ordinary Shares as of the reporting date.
Footnotes explain that these positions represent ordinary shares issuable upon vesting and settlement of restricted share units granted on June 23, 2022, May 18, 2023, June 20, 2024 and June 18, 2025. For the 2022–2024 grants, 25% of the RSUs vest on each anniversary of the grant date, while the 2025 grant vests 100% on its first anniversary. The filing reflects compensation-related equity awards rather than new market purchases or sales.